Illumina Global Healthcare Conclave Oncology 2021

Before moving to Australia, he was based in Madison, WI, USA as a Product Development Scientist for NimbleGen Systems (later Roche NimbleGen through acquisition) overseeing the launch of numerous high-density array and hybridisation-based enrichment products. His career began with 2 fellowships at the National Cancer Institute (NCI) in Bethesda, MA, USA using some of the first custom microarrays to study gene expression changes associated with the progression of cancers. He later transitioned to a new role in the Advanced Technology Center for the NCI manufacturing, developing and training researchers how to use microarrays for gene expression and comparative genomic hybridization. His focus and expertise in new technologies has led to numerous collaborations with key opinion leaders around the world resulting in publications in Nature Genetics, Nature Methods, PNAS and Human Mutation to name a few.